FemBloc Permanent Contraception Trial
-
- STATUS
- Recruiting
-
- End date
- Dec 29, 2025
-
- participants needed
- 50
-
- sponsor
- Femasys Inc.
Summary
The purpose of this study is to evaluate if changes to the FemBloc Permanent Contraceptive System are effective in increasing reliance (the ability of a woman to be able to depend on FemBloc for contraception once the treatment and confirmation test have been performed), and decreasing pregnancy rate. In addition, the study will compare the FemChec confirmation procedure to that of fluoroscopic HSG, a well-established method of confirmation.
Details
Condition | Contraception, Contraception |
---|---|
Age | 21years - 45years |
Treatment | FemBloc |
Clinical Study Identifier | NCT04273594 |
Sponsor | Femasys Inc. |
Last Modified on | 19 February 2024 |
How to participate?
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.